NCT01520818 Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes Status COMPLETED Phase PHASE3
NCT01520753 Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01519674 Treatment Intensification With Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Inadequately Controlled on Sitagliptin and Metformin Status COMPLETED Phase PHASE4
NCT01518166 Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH Status COMPLETED Phase PHASE1
NCT01518062 Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome Status COMPLETED Phase PHASE4
NCT01517568 Metabolism and Excretion of Liraglutide in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01517555 Effect of Liraglutide on Absorption of Paracetamol in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01516255 Effect of Liraglutide on Heart Frequency in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01515592 Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers Status COMPLETED Phase PHASE1
NCT01515579 Comparison of Two Liraglutide Formulations in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01515553 Bioequivalence of Two Liraglutide Formulations in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01514500 First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01514487 Comparison of Three Liraglutide Formulations in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01513590 A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01513525 Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01513473 A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01512108 Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone Status COMPLETED Phase PHASE3